Mike Stocum | Bantam Pharmaceutical – Targeting Cancer Through the Mitochondria
Update: 2025-09-22
Description
In this episode of Executive Insights for Life Sciences Innovators, we speak with Mike Stocum of Bantam Pharmaceutical, a biotech developing therapies that target cancer cells through their mitochondria. Mike shares how Bantam is advancing its lead programs and building a strategy to translate cutting-edge science into new treatment options for patients.
Learn more at genecoda.com.
Originally recorded and streamed on YouTube Live on September 19, 2025.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
